Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Cancer Research and Clinical Oncology|June 3, 2023
T cells with split CARs specific for NKG2D ligands and PD-L1 exhibit improved selectivity towards monocyte-derived cells while effective in eliminating acute myeloid leukaemia in vivoLu Sun, Guangyi Jiang, Yu Yang Ng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 29, 2023
Dynamic Stimulations with Bioengineered Extracellular Matrix-Mimicking Hydrogels for Mechano Cell Reprogramming and TherapyYufeng Shou, Xin Yong Teo, Kenny Zhuoran Wu, et al.
Biomaterials|January 22, 2025
Non-viral, high throughput genetic engineering of primary immune cells using nanostraw-mediated transfectionArun R K Kumar, Jessalyn Low, Jet Lim, et al.
ACS Nano|January 12, 2023
Dynamic Magneto-Softening of 3D Hydrogel Reverses Malignant Transformation of Cancer Cells and Enhances Drug EfficacyYufeng Shou, Xin Yong Teo, Xianlei Li, et al.
Cancer Immunology, Immunotherapy : CII|July 9, 2022
Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasisGuangyi Jiang, Yu Yang Ng, Johan C K Tay, et al.
Plos One|June 16, 2022
Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growthXi Zhang, Yu Yang Ng, Zhicheng Du, et al.
Elife|July 8, 2020
Ways to increase equity, diversity and inclusionDevang Mehta, Yaw Bediako, Charlotte M de Winde, et al.
Immunotherapy|June 24, 2020
Experimental treatment of colorectal cancer in mice with human T cells electroporated with NKG2D RNA CARZhendong Li, Zhixia Chi, Wei-Xia Ang, et al.
Immunotherapy|February 14, 2022
A CD123-specific chimeric antigen receptor augments anti-acute myeloid leukemia activity of Vγ9Vδ2 T cellsXi Zhang, Wei Xia Ang, Zhicheng Du, et al.
Elife|March 29, 2020
Mitigating the impact of conference and travel cancellations on researchers' futuresTracey Weissgerber, Yaw Bediako, Charlotte M de Winde, et al.
Pageof 6